Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Vivascardiovascular

Phys Vivas · cardiovascular

Pericardial Disease — Viva Defence

Structured DCE viva for pericardial disease: long-case defence covering constrictive pericarditis in a complex patient and short-case discussion covering JVP interpretation, pericardial knock, and the constriction vs restriction discriminator.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
Structured DCE viva for pericardial disease: long-case defence covering constrictive pericarditis in a complex patient and short-case discussion covering JVP interpretation, pericardial knock, and the constriction vs restriction discriminator.

Pericardial Disease Viva

Long Case Viva Defence

Candidate's opening statement (model answer)

"Mr Thompson is a 62-year-old retired schoolteacher who presents with a 6-month history of progressive exertional dyspnoea, bilateral leg swelling, and abdominal distension. He has a background of Hodgkin lymphoma treated with mediastinal radiotherapy and ABVD chemotherapy 20 years ago, type 2 diabetes, and hypertension. [1]

His past history also includes aortic valve replacement (bioprosthetic) 5 years ago for radiation-induced aortic stenosis, and permanent atrial fibrillation. [1]

On examination, his JVP is elevated to 10 cm above the sternal angle with a prominent Y descent that rises further on inspiration — a Kussmaul sign. A high-pitched early diastolic sound is audible at the left lower sternal border — a pericardial knock. He has hepatomegaly 4 cm below the costal margin, moderate ascites, and pitting oedema to the knees bilaterally. [1]

His echocardiogram shows an ejection fraction of 58%, thickened pericardium, a diastolic septal bounce, preserved medial e-prime of 12 cm/s, and expiratory diastolic flow reversal in the hepatic veins. CT confirms pericardial thickness of 4 mm. Cardiac MRI shows pericardial late gadolinium enhancement but no myocardial LGE. BNP is 140. [1]

His main problems are:

  1. Constrictive pericarditis, radiation-induced, with an inflammatory (possibly transient) component given the pericardial LGE
  2. Radiation-induced valvular disease — prior bioprosthetic AVR (needs surveillance for degeneration)
  3. Radiation-induced coronary artery disease — needs assessment
  4. Permanent atrial fibrillation — on apixaban
  5. Type 2 diabetes and hypertension
  6. Chronic right heart failure with cardiac cirrhosis risk
  7. Polypharmacy and complex medication management [1]

My working diagnosis is constrictive pericarditis secondary to mediastinal radiotherapy, with the possibility of a transient inflammatory component. I need to differentiate this from radiation-induced restrictive cardiomyopathy, which can coexist. My priority is confirming the diagnosis with the echo and MRI findings, trialling a period of anti-inflammatory therapy given the pericardial LGE, and planning for pericardiectomy if the constriction is fixed." [1]

Examiner probing questions and model answers

Q1: "How confident are you that this is constriction and not restriction, given the radiation history?" [1]

"My confidence is moderate to high but not absolute, and that is the key issue. Five features favour constriction: the preserved medial e-prime of 12 cm/s — the single best non-invasive discriminator, because it shows the myocardium is normal and the restriction is in the pericardium; the diastolic septal bounce on echo, reflecting ventricular interdependence; the expiratory hepatic vein flow reversal, also specific for constriction; the pericardial thickness of 4 mm on CT; and the cardiac MRI showing pericardial late gadolinium enhancement with no myocardial LGE — if this were restrictive cardiomyopathy I would expect myocardial LGE, such as subendocardial circumferential enhancement for amyloid. [1]

However, I acknowledge that radiation damages both the pericardium AND the myocardium, so a mixed picture is possible. The preserved e-prime and the absence of myocardial LGE are reassuring that the myocardium is not the dominant problem. If the patient were to fail pericardiectomy or show clear myocardial disease on further imaging, I would reconsider a mixed constriction-restriction physiology." [1]

Q2: "What is the significance of the pericardial late gadolinium enhancement on the MRI?" [1]

"Pericardial late gadolinium enhancement indicates active pericardial inflammation, not just chronic fibrosis. This raises the possibility of transient — or reversible — constriction. Studies show that up to 20 percent of constrictive presentations are transient and can resolve with anti-inflammatory therapy (NSAIDs or colchicine, sometimes a short steroid taper) over 2 to 3 months. Given this patient has pericardial LGE and a relatively recent symptom onset of 6 months, I would trial a period of anti-inflammatory therapy before committing to pericardiectomy — specifically colchicine 0.5 mg twice daily, with clinical and echo reassessment at 3 months. If the constrictive physiology resolves, surgery is avoided." [1]

Q3: "Would you perform right and left heart catheterisation?" [1]

"Yes — cardiac catheterisation provides haemodynamic confirmation and is particularly valuable when non-invasive imaging is equivocal or when mixed physiology is suspected. In constrictive pericarditis I expect: equalisation of LV and RV diastolic pressures (within 5 mmHg); the dip-and-plateau or square-root sign on the ventricular pressure trace (rapid early diastolic filling followed by an abrupt plateau as the ventricle hits the rigid pericardium); an RVEDP to RV systolic pressure ratio over one-third; and a PA systolic pressure usually under 55 mmHg. If the PA systolic is markedly elevated or the LV diastolic pressure significantly exceeds RV, that points toward restrictive cardiomyopathy or mixed disease. In this patient, with prior valve surgery and radiation, catheterisation would also allow coronary angiography to assess for radiation-induced coronary disease." [1]

Q4: "The patient has a bioprosthetic aortic valve replaced 5 years ago. How does this complicate pericardiectomy?" [1]

"A prior sternotomy and mediastinal radiotherapy both make pericardiectomy technically more challenging and higher risk. Repeat sternotomy carries risk of injury to adherent structures, particularly the right ventricle and prior grafts if CABG was done. The radiation causes dense fibrosis and adhesions in the mediastinum and may have thinned the right ventricular free wall. Perioperative mortality for pericardiectomy is 5 to 15 percent overall but is higher — up to 15 to 20 percent — in irradiated and reoperative patients. The case must go to a specialist cardiothoracic centre with experience in complex redo pericardiectomy. The bioprosthetic AVR also needs assessment for degeneration, as bioprosthetic valves last 10 to 15 years on average — at 5 years it is probably still functioning, but I would assess the gradients on echo." [1]

Q5: "How would you manage the right heart failure symptoms while awaiting the trial of medical therapy or surgery?" [1]

"Cautious diuresis — frusemide 20 to 40 mg daily or spironolactone 12.5 to 25 mg daily for the ascites and oedema. The key principle is to avoid over-diuresis: these patients are preload-dependent because the rigid pericardium prevents ventricular filling, and aggressive diuresis can precipitate hypotension and renal failure. I would aim for symptom relief and a modest weight reduction, monitoring renal function and blood pressure closely. I would also restrict dietary sodium and fluid if the ascites is problematic." [1]

Q6: "What is the patient's prognosis and how would you discuss it?" [1]

"The prognosis depends on whether the constriction is transient or fixed. If transient and responsive to anti-inflammatory therapy, the outlook is favourable with medical management. If fixed and requiring pericardiectomy, the 5-year survival after surgery is 70 to 80 percent in well-selected patients, but is worse in irradiated patients because of the comorbid myocardial, coronary, and valvular damage. The patient needs to understand that pericardiectomy is major surgery with significant risk, that the decision involves balancing this risk against the progressive nature of untreated constriction, and that a multidisciplinary approach at a specialist centre is essential. I would discuss the possibility of a mixed constriction-restriction picture — in which case surgery may not fully resolve symptoms — honestly but constructively. Shared decision-making with the patient and cardiothoracic team is central." [1]


Short Case Discussion

Scenario: "Examine this patient's cardiovascular system"

Candidate presentation (model): [1]

"I examined Mrs Chen's cardiovascular system. She is comfortable at rest at 45 degrees. There is no clubbing, pallor, or cyanosis. The pulse is irregularly irregular at 88 beats per minute, normal volume. Blood pressure is 116/74. [1]

The JVP is elevated approximately 8 cm above the sternal angle. The waveform shows a prominent Y descent — a rapid collapse in early diastole. On inspiration, the JVP rises rather than falls — a Kussmaul sign. [1]

The apex beat is impalpable in the 5th intercostal space, mid-clavicular line. On auscultation, the heart sounds are normal with a high-pitched early diastolic sound approximately 100 milliseconds after the second heart sound, best heard at the left lower sternal border — consistent with a pericardial knock. There are no murmurs. [1]

Examination of the abdomen reveals hepatomegaly with the liver edge 4 cm below the costal margin, and shifting dullness consistent with moderate ascites. There is pitting oedema to the mid-shin bilaterally. [1]

In summary, these findings are consistent with constrictive pericarditis — the raised JVP with a prominent Y descent, the Kussmaul sign, the pericardial knock, and the signs of chronic right heart failure." [1]

Examiner: "Explain the Kussmaul sign." [1]

"The Kussmaul sign is a paradoxical rise in the JVP on inspiration. Normally, inspiration reduces intrathoracic pressure, increases venous return to the right heart, and the JVP falls. In constrictive pericarditis, the rigid pericardium cannot expand to accommodate the increased venous return, so the extra blood backs up into the systemic veins and the JVP rises. It indicates that the right heart is encased in a non-compliant pericardium. The differential for a Kussmaul sign includes constrictive pericarditis, severe right ventricular failure, severe tricuspid regurgitation, and right ventricular infarction — but in the context of a pericardial knock and prominent Y descent, constriction is the most likely diagnosis." [1]

Examiner: "What produces the pericardial knock?" [1]

"The pericardial knock is a high-pitched early diastolic sound produced by the abrupt cessation of rapid ventricular filling. In early diastole, blood rushes into the ventricle rapidly because the atrial pressure is elevated — this is why the Y descent is deep and rapid. But the expanding ventricle very quickly hits the rigid, non-compliant pericardium and cannot expand further. This sudden stop in ventricular filling produces the knock. It is the constrictive equivalent of the third heart sound in heart failure — both result from rapid early diastolic filling, but the pericardial knock occurs earlier (60 to 120 milliseconds after S2) and is higher-pitched than the S3 because the abrupt stop against a rigid pericardium generates a sharper sound." [1]

Examiner: "How would you confirm the diagnosis?" [1]

"I would request an echocardiogram as the first-line imaging test — looking for pericardial thickening, a diastolic septal bounce, a restrictive mitral inflow pattern with respiratory variation, preserved medial e-prime on tissue Doppler (annulus paradoxus), and expiratory hepatic vein flow reversal. I would then request a cardiac CT to measure pericardial thickness and look for calcification, and a cardiac MRI to assess for pericardial late gadolinium enhancement indicating active inflammation and to evaluate the myocardium. If non-invasive imaging is equivocal, right and left heart catheterisation would provide haemodynamic confirmation with equalised diastolic pressures and the dip-and-plateau sign. The essential step is differentiating constrictive pericarditis from restrictive cardiomyopathy — the preserved medial e-prime is the single best non-invasive discriminator." [1]

References

  1. [1]Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J, 2015.PMID 26320109
  2. [2]Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis N Engl J Med, 2013.PMID 23992557
  3. [3]Imazio M, Brucato A, Spodick DH, Adler Y. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review J Am Coll Cardiol, 2020.PMID 31918837
  4. [4]Brucato A, Imazio M, Pauletto R, et al. First DMD Drug Gains Approval JAMA, 2016.PMID 27802526